NCT00000644View on ClinicalTrials.gov

A Phase II Safety and Efficacy Study of Clarithromycin in the Treatment of Disseminated M. Avium Complex (MAC) Infections in Patients With AIDS

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

Not specified

Primary Completion Date

November 30, 1997

Conditions
Mycobacterium Avium-intracellulare InfectionHIV Infections
Interventions
DRUG

Clarithromycin

Trial Locations (3)

21287

Johns Hopkins Hosp, Baltimore

60612

Rush Presbyterian - Saint Luke's Med Ctr, Chicago

900331079

Univ of Southern California / LA County USC Med Ctr, Los Angeles

Sponsors

Collaborators (1)

Abbott
All Listed Sponsors
collaborator

Abbott

INDUSTRY

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000644 - A Phase II Safety and Efficacy Study of Clarithromycin in the Treatment of Disseminated M. Avium Complex (MAC) Infections in Patients With AIDS | Biotech Hunter | Biotech Hunter